Edding Genor Group Holdings (HKSE:06998) Altman Z-Score: 1.56 (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06998 Edding Genor Group Holdings Ltd HKSE:06998
15 GF Score
Price HK$1.53
! 1 Warning Sign
View Full Analysis

What is Edding Genor Group Holdings Altman Z-Score?

Edding Genor Group Holdings HKSE:06998 +0.33% 15 Altman Z-Score is 1.56 as of Aug. 27, 2026. GuruFocus rates HKSE:06998 with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 951 Drug Manufacturers companies, Edding Genor Group Holdings ranks worse than 105152.37% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Edding Genor Group Holdings has a Altman Z-Score of 1.56, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Edding Genor Group Holdings's Altman Z-Score or its related term are showing as below:


Edding Genor Group Holdings  (HKSE:06998) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Edding Genor Group Holdings Altman Z-Score Related Terms


Edding Genor Group Holdings Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Edding Genor Group Holdings's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edding Genor Group Holdings Altman Z-Score Chart

Edding Genor Group Holdings Annual Data
Trend Dec24 Dec25
Altman Z-Score
0.00 0.00

Edding Genor Group Holdings Semi-Annual Data
Dec24 Dec25
Altman Z-Score 0.00 0.00

HKSE:06998 vs ZTS: Altman Z-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Edding Genor Group Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edding Genor Group Holdings Altman Z-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Edding Genor Group Holdings's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Edding Genor Group Holdings's Altman Z-Score falls into.


HKSE:06998
15GF Score
Edding Genor Group Holdings Ltd HKSE:06998
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edding Genor Group Holdings Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Edding Genor Group Holdings's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*-0.0016+1.4*0.1851+3.3*0.1001+0.6*1.0009+1.0*0.3767
=1.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$7,294 Mil.
Total Current Assets was HK$2,431 Mil.
Total Current Liabilities was HK$2,443 Mil.
Retained Earnings was HK$1,350 Mil.
Pre-Tax Income was HK$548 Mil.
Interest Expense was HK$-182 Mil.
Revenue was HK$2,748 Mil.
Market Cap (Today) was HK$3,042 Mil.
Total Liabilities was HK$3,040 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2431.026 - 2442.507)/7293.994
=-0.0016

X2=Retained Earnings/Total Assets
=1350.407/7293.994
=0.1851

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(548.238 - -182.093)/7293.994
=0.1001

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3042.405/3039.725
=1.0009

X5=Revenue/Total Assets
=2747.961/7293.994
=0.3767

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Edding Genor Group Holdings has a Altman Z-Score of 1.56 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 1.56 mean?
Edding Genor Group Holdings (HKSE:06998) has a Altman Z-Score of 1.56 as of Aug. 27, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Edding Genor Group Holdings and its competitors. According to the industry distribution chart, Edding Genor Group Holdings ranks #999999 out of 951 companies in the Drug Manufacturers industry.
Is Edding Genor Group Holdings' Altman Z-Score too high?
Edding Genor Group Holdings' current Altman Z-Score is 1.56. The Drug Manufacturers industry median Altman Z-Score is 3.29. Edding Genor Group Holdings' value of 1.56 is 52.6% below this industry median. Based on the distribution chart, Edding Genor Group Holdings ranks #999999 out of 951 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Edding Genor Group Holdings has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Edding Genor Group Holdings' Altman Z-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Edding Genor Group Holdings ranks #999999 out of 951 companies for Altman Z-Score. This places Edding Genor Group Holdings in the lower half of its industry. The industry median Altman Z-Score is 3.29. Edding Genor Group Holdings' value of 1.56 is 52.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Drug Manufacturers company?
The median Altman Z-Score among Drug Manufacturers companies is 3.29, based on 951 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edding Genor Group Holdings's current Altman Z-Score of 1.56 is 52.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Edding Genor Group Holdings and its competitors. For the Drug Manufacturers industry, the median Altman Z-Score is 3.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edding Genor Group Holdings's current Altman Z-Score is 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edding Genor Group Holdings stock overvalued right now?
Edding Genor Group Holdings (HKSE:06998) has a current Altman Z-Score of 1.56. The current Altman Z-Score is 1.56 and 52.6% below the Drug Manufacturers industry median of 3.29. Edding Genor Group Holdings' overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Edding Genor Group Holdings (HKSE:06998), the current Altman Z-Score is 1.56 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Edding Genor Group Holdings Business Description

Address No. 36 Doukou Road, Room 406, Building 1, Hengqin New Area, Guangdong Province, Zhuhai, CHN
Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.
15GF Score

Get the complete analysis for HKSE:06998

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.53
Price